What is the address of PHARMETAL?

The registered office of PHARMETAL is located at Andreas Vesaliuslaan 11, 1780 Wemmel.

Is PHARMETAL still active?

Yes. According to the CBE (29 October 2026) PHARMETAL is active, legal situation “Normale toestand”, started on 12 June 1979.

Is PHARMETAL registered on Peppol?

No, PHARMETAL is currently not registered on the Peppol network.

What is the enterprise number of PHARMETAL?

The enterprise number of PHARMETAL is BE0419522921.

When was PHARMETAL founded?

PHARMETAL was founded on 12 June 1979.

Who are the directors of PHARMETAL?

According to the 2025 annual accounts, the directors of PHARMETAL are: John DESCURIEUX, Huguette DE DONDER.

Is PHARMETAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 June 1979; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMETAL make in 2025?

PHARMETAL recorded a loss after taxes of € 18,466 in financial year 2025.

What is the revenue of PHARMETAL?

As a small company, PHARMETAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -1,800.

PHARMETAL (Private Limited) - Wemmel - BE0419522921

Dossier PHARMETAL, printed on 29 October 2026 from databakkes.be/en/0419522921/pharmetal. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

PHARMETAL from Wemmel, company number BE0419522921, closed financial year 2025 with a result of € -18,466 after tax. For that financial year PHARMETAL recorded a gross margin of € -1,800 and equity of € 371,829. Compared with financial year 2024, the result moved from € 16,351 to € -18,466. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 30, 2026.

What it is worth Healthy

€ 371,829

▼ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -18,466

▼ still € 16,351 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 3,578

▼ 70% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 371,829.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,905

▲ € 1,735 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,172

▼ 27% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -1,966 Gross margin 2022: € -1,966 First fiscal year in the series	€ -4,771 Gross margin 2023: € -4,771 ▼ € 2,805 vs 2022 (€ -1,966) Unfavourable step	€ -2,976 Gross margin 2024: € -2,976 ▲ € 1,795 vs 2023 (€ -4,771) Favourable step	€ -1,800 Gross margin 2025: € -1,800 ▲ € 1,175 vs 2024 (€ -2,976) Favourable step	▲ € 1,175
Profit after taxes	€ 8,061 Profit after taxes 2022: € 8,061 First fiscal year in the series	€ -1,436 Profit after taxes 2023: € -1,436 ▼ € 9,498 vs 2022 (€ 8,061) Unfavourable step	€ 16,351 Profit after taxes 2024: € 16,351 ▲ € 17,787 vs 2023 (€ -1,436) Favourable step	€ -18,466 Profit after taxes 2025: € -18,466 ▼ € 34,817 vs 2024 (€ 16,351) Unfavourable step	▼ € 34,817
Equity	€ 395,840 Equity 2022: € 395,840 First fiscal year in the series	€ 373,944 Equity 2023: € 373,944 ▼ 6% vs 2022 (€ 395,840) Unfavourable step	€ 390,295 Equity 2024: € 390,295 ▲ 4% vs 2023 (€ 373,944) Favourable step	€ 371,829 Equity 2025: € 371,829 ▼ 5% vs 2024 (€ 390,295) Unfavourable step	▼ 5%
Total debts	€ 1,682 Total debts 2022: € 1,682 First fiscal year in the series	€ 1,802 Total debts 2023: € 1,802 ▲ 7% vs 2022 (€ 1,682) Unfavourable step	€ 4,081 Total debts 2024: € 4,081 ▲ 126% vs 2023 (€ 1,802) Unfavourable step	€ 4,077 Total debts 2025: € 4,077 Unchanged (€ 4,081) Favourable step
Cash	€ 390,926 Cash 2022: € 390,926 First fiscal year in the series	€ 9,975 Cash 2023: € 9,975 ▼ 97% vs 2022 (€ 390,926) Unfavourable step	€ 11,864 Cash 2024: € 11,864 ▲ 19% vs 2023 (€ 9,975) Favourable step	€ 3,578 Cash 2025: € 3,578 ▼ 70% vs 2024 (€ 11,864) Unfavourable step	▼ 70%
Retained profit	€ 377,240 Retained profit 2022: € 377,240 First fiscal year in the series	€ 373,944 Retained profit 2023: € 373,944 ▼ 1% vs 2022 (€ 377,240) Unfavourable step	€ 390,295 Retained profit 2024: € 390,295 ▲ 4% vs 2023 (€ 373,944) Favourable step	€ 371,829 Retained profit 2025: € 371,829 ▼ 5% vs 2024 (€ 390,295) Unfavourable step	▼ 5%
Balance sheet total	€ 397,522 Balance sheet total 2022: € 397,522 First fiscal year in the series	€ 375,746 Balance sheet total 2023: € 375,746 ▼ 5% vs 2022 (€ 397,522) Unchanged	€ 394,375 Balance sheet total 2024: € 394,375 ▲ 5% vs 2023 (€ 375,746) Unchanged	€ 375,906 Balance sheet total 2025: € 375,906 ▼ 5% vs 2024 (€ 394,375) Unchanged	▼ 5%

Key figures of PHARMETAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMETAL?

What happened at PHARMETAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 30, 2026 New annual accounts for financial year 2025: loss of € 18,466 (▼ € 34,817 vs 2024). filed late Source: NBB ↗
Jul 1, 1979 New establishment in Meise. KBO
Jun 12, 1979 Start of the company according to the CBE. KBO

In short

From € 8,061 profit in 2022 to € 18,466 loss in 2025.

Paid € 8,493 in corporate taxes since 2022.

Best year ever: 2024, with € 16,351 profit.

Original PDFs at the National Bank ↗

Management

John DESCURIEUX Huguette DE DONDER

PHARMETAL

Behind PHARMETAL are John DESCURIEUX and Huguette DE DONDER.

Directors

According to the 2025 annual accounts

John DESCURIEUX

Manager

Huguette DE DONDER

Manager

Establishments

Establishment units

Physical locations of this company

Registered office

Andreas Vesaliuslaan 11

1780 Wemmel

2.036.064.939

Nieuwelaan 1 A

1860 Meise

Active since 1 July 1979

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0419.522.921
VAT number: BE 0419.522.921
Registered office: Andreas Vesaliuslaan 11, 1780 Wemmel
Names & denominations: PHARMETAL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 12 June 1979
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗